Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
The fact that liraglutide is prescribed to be taken daily rather than weekly means larger doses may be required to trigger comparable weight loss
Blood-sugar levels (HbA1c), weight, cholesterol levels and other health markers were monitored, while any side-effects were recorded
The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component)
When your body adapts to the physiological changes, these symptoms start to improve or resolve completely
Competitive pricing and subscription refill services further encourage patient adoption